Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM6422828 |
Wild type GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422829 |
Wild type GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422830 |
Flcn KO GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422831 |
Flcn KO GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422832 |
PBS treatment GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422833 |
PBS treatment GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422834 |
Glutamine treatment GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422835 |
Glutamine treatment GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422836 |
Anti-PD1 antibody treatment GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422837 |
Anti-PD1 antibody treatment GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422838 |
Glutamine and anti-PD1 antibody treatment GEX1
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6422839 |
Glutamine and anti-PD1 antibody treatment GEX2
|
SRA | 1 |
|
Hongbo Chi | May 24, 2023 | |||
GSM6761464 |
TF CRISPRi screen donor 1, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 | |||
GSM6761465 |
TF CRISPRi screen donor 2, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 | |||
GSM6761466 |
TF CRISPRi screen donor 3, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 | |||
GSM6761467 |
TF CRISPRa screen donor 1, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 | |||
GSM6761468 |
TF CRISPRa screen donor 2, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 | |||
GSM6761469 |
TF CRISPRa screen donor 3, day 10
|
SRA | 1 |
|
Sean McCutcheon | May 24, 2023 |